Poster Number: 1563P

ESMO 2025

Caicun Zhou¹, Yanqiao Zhang², Sook Ryun Park³, Sanjeev Deva⁴, Yi Ba⁵,
Yongsheng Wang⁶, Jong-Mu Sun⁷, Keun-Wook Lee⁸, Victoria Chang⁹,
Cunjing Yu¹⁰, Teresa Zhang⁹, Heather Zhang⁹, Yue Tian¹⁰,
Kirsha Naicker¹¹, Timothy A. Yap¹²

¹ Shanghai Pulmonary Hospital, Shanghai, China
² Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
³ Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
⁴ Auckland City Hospital, Auckland, New Zealand
⁵ Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁶ West China Hospital, Sichuan University, Chengdu, Sichuan, China
⁷ Samsung Medical Center, Seoul, Republic of Korea
⁸ Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
⁹ BeOne Medicines, Ltd, San Carlos, CA, USA
¹⁰ BeOne Medicines, Ltd, Beijing, China
¹¹ BeOne Medicines, Ltd, London, UK
¹² The University of Texas MD Anderson Cancer Center, Houston, TX, USA

1125-BGB-A317-MRC-032